Skip to main content
TipRanks
Go Ultimate75% OFF

Biorem Inc (BRM) AI Stock Analysis

21 Followers
TSE:BRM

Biorem Inc

(TSXV:BRM)

Select Model
Rating:73Outperform
Price Target:CAD 4.50â–¼(-2.17% Downside)
Action:upgraded
Date:11/10/26

The company's operational turnaround and strong balance sheet are significant strengths, but the overall score is constrained by a severe cash conversion problem where reported profits are not translating into cash flow. Positive technical momentum and a low P/E ratio provide support, though the stock is nearing overbought levels.

Positive Factors
Profitability and Revenue GrowthBiorem combines measurable revenue growth with healthy operating profitability, indicating that its environmental-control offerings can generate attractive economics. Improved margins provide internal funding capacity and may support continued investment in engineering, project delivery, and customer support.
Negative Factors
Weak Cash ConversionThe large gap between reported profit and cash generation weakens earnings quality and reduces the funds currently available for reinvestment, debt reduction, or shareholder returns. Persistent conversion pressure could make results more dependent on working-capital movements and project timing.

Biorem Inc (BRM) vs. iShares MSCI Canada ETF (EWC)

-20%0%20%40%60%80%TSE:BRM+72.28%EWC+11.69%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
CAD 81.66M
Dividend Yield
―
Average Volume (3M)
17.23K
Price to Earnings (P/E)
9.7
Beta (1Y)
0.27
Revenue Growth
61.47%
EPS Growth
257.78%
Country
Canada
Employees
57
Sector
Industrials
Sector Strength
63
Industry
Industrial - Pollution & Treatment Controls

Biorem Inc Business Overview & Revenue Model

Company Description

BioRem Inc. is a clean technology engineering firm specializing in the development, manufacturing, and global distribution of environmental air purification systems. These systems are engineered to combat a range of airborne contaminants, including f...

How the Company Makes Money

Biorem makes money primarily by selling air emissions control projects and related equipment to customers that need odor and VOC control. Revenue is generated from (1) engineered system sales, where Biorem designs and supplies biotrickling filter/bio...

Biorem Inc Financial Statement Overview

Summary

Strong income statement and balance sheet, marked by robust revenue growth, expanding margins, and successful deleveraging. However, the overall financial health is weighed down by a critical cash flow weakness, as TTM operating cash flow to net income is just 0.02, indicating poor earnings quality.

Income Statement

82Very Positive

Balance Sheet

78Positive

Cash Flow

45Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Dec 2021
Income Statement
Total Revenue56.08M42.36M37.42M25.17M28.86M24.48M
Gross Profit17.89M12.59M10.06M7.02M8.76M6.24M
EBITDA10.80M7.05M4.82M3.45M2.99M2.68M
Net Income7.75M4.82M3.04M2.18M1.61M1.30M
Balance Sheet
Total Assets36.22M33.58M28.51M24.08M20.73M19.17M
Cash, Cash Equivalents and Short-Term Investments7.94M11.50M5.21M2.29M3.78M4.47M
Total Debt2.31M2.83M3.56M4.19M4.75M5.67M
Total Liabilities15.82M18.65M17.89M17.36M16.21M17.20M
Stockholders Equity20.41M14.93M10.63M6.72M4.52M1.96M
Cash Flow
Free Cash Flow49.90K7.27M3.31M-62.84K1.24M3.71M
Operating Cash Flow482.09K7.64M3.69M490.03K1.44M3.78M
Investing Cash Flow-432.20K-367.83K-372.00K-552.87K-203.29K-75.98K
Financing Cash Flow-575.72K-767.05K-572.04K-1.33M-951.80K-7.56M

Biorem Inc Technical Analysis

Technical Analysis SentimentPositive
Last Price4.60

Price Trends

50DMA3.79Positive
100DMA3.60Positive
200DMA3.23Positive

Market Momentum

MACD0.26Negative
RSI68.14Neutral
STOCH67.97Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:BRM, the sentiment is Positive. The current price of 4.60 is above the 20-day moving average (MA) of 4.19, above the 50-day MA of 3.79, and above the 200-day MA of 3.23, indicating a bullish trend. The MACD of 0.26 indicates Negative momentum. The RSI at 68.14 is Neutral, neither overbought nor oversold. The STOCH value of 67.97 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:BRM.

Biorem Inc Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

TSE:BRM against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TSE:BRMTSE:BRM73OutperformCAD 81.66M9.7345.45%―61.47%257.78%
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
TSE:TMGTSE:TMG58NeutralCAD 24.79M30.8516.53%―16.89%―
TSE:GRNTSE:GRN54NeutralCAD 27.26M-6.94-17.65%―4.36%-263.33%
TSE:QSTTSE:QST42NeutralCAD 5.55M-1.72-16.34%―-74.07%-251.51%
TSE:SHRCTSE:SHRC39UnderperformCAD 9.91M-2.76109.61%―-22.75%5.86%

* Industrials Sector Average

Performance Comparison

-50%0%50%100%TSE:BRMTSE:SHRCTSE:QSTTSE:TMGTSE:GRNDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TSE:BRM and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TSE:BRMBiorem Inc4.602.0479.69%
TSE:SHRCSharc International Systems Inc.0.06-0.01-14.29%
TSE:QSTQuestor Technology0.20-0.20-50.00%
TSE:TMGThermal Energy International0.140.0220.83%
TSE:GRNGreenlane Renewables0.17-0.03-17.07%

Biorem Inc Corporate Events

Financial Disclosures

BIOREM Reports Record Third-Quarter Revenue and Earnings

Positive
Nov 4, 2026

BIOREM Inc., a clean technology company providing air emissions control systems to municipal and industrial customers, reported record third-quarter results for 2026. Revenue rose 48% year over year to $16.6 million, while net earnings increased to $...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 10, 2026